A program to improve PrEP use among young women in Kenya

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

PrEP My Way is an innovative program designed to enhance the delivery of pre-exposure prophylaxis (PrEP) for HIV prevention among young women in Kisumu, Kenya. The program includes clinic-based initiation of PrEP, followed by peer-delivered kits that provide HIV self-testing, PrEP refills, and other health services. The study aims to empower participants by offering choices in PrEP formulations and adherence support, while addressing stigma and barriers to PrEP use. A total of 432 women aged 16-24 will be enrolled and randomized to assess the effectiveness of the intervention compared to standard care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* young women (age 16-24 years)
* initiating PrEP at the recruitment site (this criterion subsumes all necessary safety assessments for starting PrEP, including HIV-negative status and for those taking FTC/TDF normal renal function and lack of Hepatitis B infection)
* resident in Kisumu County
* phone ownership
* ability to understand KiSwahili, DhoLuo, and/or English

Exclusion Criteria:

* inability to provide informed consent (e.g., intoxication)

Where it's running

• Kenya Medical Research Institute
  Kisumu, Kenya Recruiting

Study contacts

• Principal investigator: Jessica Haberer, MD, MS — Director of Research, Center for Global Health
• Study coordinator: Lindsey Garrison, MPH
• Email: legarrison@mgh.harvard.edu
• Phone: 617-643-9195

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Peer-led Dynamic Choice HIV Prevention for Women

  This trial tests a peer-led HIV prevention approach to see if it helps women at higher risk in Uganda better prevent HIV than standard care.

  Recruiting University of California, San Francisco · Kampala · NCT07787988

• Improving long-term medication adherence for HIV treatment

  This study is testing whether daily text messages and rewards can help people starting HIV treatment stick to their medication plan over the long term.

  Recruiting Rand · Kampala · NCT06949774

• Using a mobile app to reduce HIV infections in young men and non-binary individuals

  This study is testing a mobile app designed to help young men and non-binary individuals reduce their risk of getting HIV.

  Recruiting at 2 sites Columbia University · Chicago, Illinois and 1 other locations · NCT06741631

• Mobile intervention for HIV prevention in young men who have sex with men

  This study is testing a mobile program that helps young men who have sex with men learn about and access HIV prevention methods, like PrEP, to see if it can reduce their risk of getting HIV.

  Recruiting Columbia University · New York, New York · NCT06741618

• Using a pill sensor system to improve HIV treatment adherence

  This study is testing a new pill sensor system to see if it helps adults with HIV stick to their treatment better and improve their health.

  Recruiting Phase 2 University of California, Los Angeles · Los Angeles, California · NCT06480578

• Using community health workers and mobile health to improve HIV treatment outcomes

  This study is testing whether using community health workers and mobile health tools can help people with HIV in the Deep South stick to their treatment and improve their health outcomes.

  Recruiting at 5 sites Columbia University · Hobson City, Alabama and 4 other locations · NCT06472206

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.